Biotechnology
The Biotechnology industry has a total of 612 stocks, with a combined market cap of $1.07 trillion and total revenue of $105.59 billion.
Market Cap
1.07T
Revenue
105.59B
Profits
-42.95B
PE Ratio
n/a
Profit Margin
-40.68%
Dividend Yield
0.04%
612 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 106.82B | -3.33% | 1,539,934 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.12B | -3.10% | 1,347,764 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.87B | -0.34% | 886,187 | 3.21B |
| 4 | ARGX | argenx SE | 56.30B | -0.43% | 324,317 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.39B | 0.92% | 1,580,340 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 39.15B | -2.78% | 233,350 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.39B | -1.07% | 592,701 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.30B | -2.10% | 3,801,228 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.89B | -2.47% | 2,661,642 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.28B | 0.76% | 1,122,041 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.15B | -0.88% | 6,930,404 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.63B | -0.07% | 2,008,557 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.98B | -2.19% | 476,256 | 758.59M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.63B | -0.08% | 1,269,810 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.62B | -0.61% | 230,277 | 740.64M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.33B | -1.49% | 1,924,788 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.99B | -0.67% | 3,614,675 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.34B | -1.27% | 2,169,683 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.70B | -2.46% | 1,823,937 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.68B | 0.07% | 2,894,937 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.10B | -2.95% | 2,053,563 | 3.09B |
| 22 | MRNA | Moderna, Inc. | 9.45B | -2.97% | 9,337,482 | 2.23B |
| 23 | TECH | Bio-Techne Corporation | 9.01B | -0.58% | 1,256,576 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.64B | -0.77% | 796,981 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.26B | 0.21% | 1,545,662 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.00B | 1.32% | 432,981 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 7.92B | -2.10% | 2,080,998 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.79B | 2.77% | 2,167,591 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.40B | -0.48% | 490,935 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.28B | 0.25% | 1,844,411 | 56.61M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.89B | 0.28% | 3,998,952 | 302.00K |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.88B | 2.63% | 796,445 | 174.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 6.73B | 0.42% | 1,746,718 | 649.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.37B | -1.82% | 1,613,883 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.07B | -1.42% | 956,403 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.92B | -0.29% | 222,951 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.39B | -3.71% | 2,709,181 | 572.98M |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 5.32B | 0.88% | 989,021 | 209.22M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.32B | 4.61% | 3,760,845 | - |
| 40 | ACLX | Arcellx, Inc. | 5.18B | -0.38% | 1,051,425 | 35.90M |
| 41 | LEGN | Legend Biotech Corporation | 5.18B | -4.72% | 2,909,039 | 909.05M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.83B | -5.12% | 1,713,756 | 38.34M |
| 43 | PRAX | Praxis Precision Medicines, Inc. | 4.73B | 2.82% | 729,580 | 7.46M |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.67B | 0.95% | 505,051 | 43.74M |
| 45 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.02% | 1,422,698 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.43B | -2.82% | 1,899,672 | 531.90M |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.38B | -0.73% | 993,650 | 35.24M |
| 48 | CELC | Celcuity Inc. | 4.36B | 2.96% | 750,217 | - |
| 49 | APGE | Apogee Therapeutics, Inc. | 4.31B | -0.13% | 485,489 | - |
| 50 | BLTE | Belite Bio, Inc | 4.20B | -2.29% | 59,259 | - |
| 51 | CNTA | Centessa Pharmaceuticals plc | 4.09B | -1.27% | 1,477,263 | 15.00M |
| 52 | VKTX | Viking Therapeutics, Inc. | 4.07B | -4.56% | 4,596,068 | - |
| 53 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -0.26% | 758,168 | 1.54M |
| 54 | IMVT | Immunovant, Inc. | 4.06B | -2.24% | 902,328 | - |
| 55 | SRRK | Scholar Rock Holding Corporation | 4.05B | -0.29% | 2,641,897 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 3.91B | -2.94% | 1,449,532 | 1.05B |
| 57 | ADMA | ADMA Biologics, Inc. | 3.80B | 1.66% | 2,770,506 | 488.56M |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.62B | -2.43% | 449,984 | 471.79M |
| 59 | CGON | CG Oncology, Inc. | 3.44B | 0.12% | 620,254 | 2.17M |
| 60 | IRON | Disc Medicine, Inc. | 3.43B | 1.11% | 676,497 | - |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 2.24% | 3,377,891 | 317.93M |
| 62 | MLYS | Mineralys Therapeutics, Inc. | 3.33B | -2.93% | 1,547,292 | - |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 0.18% | 352,243 | 366.10M |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.17B | -1.58% | 1,256,798 | 435.83M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.14B | 0.10% | 558,919 | 7.50M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.07B | -2.99% | 1,066,389 | 630.60M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.07B | -1.53% | 61,851 | 664.23M |
| 68 | FOLD | Amicus Therapeutics, Inc. | 3.00B | 1.46% | 4,058,064 | 598.70M |
| 69 | AAPG | Ascentage Pharma Group International | 2.99B | 0.63% | 1,294 | 54.52M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.94B | -1.72% | 1,990,652 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.91B | -1.69% | 924,124 | 214.83M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | -0.66% | 1,023,442 | 578.20M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.74B | 0.31% | 1,131,520 | 70.79M |
| 74 | LQDA | Liquidia Corporation | 2.58B | -1.85% | 2,216,162 | 69.22M |
| 75 | OCUL | Ocular Therapeutix, Inc. | 2.58B | 2.89% | 2,842,366 | 55.78M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 2.52B | -3.17% | 1,351,287 | 98.68M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.48B | -3.20% | 1,597,564 | - |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.46B | -1.42% | 1,995,191 | 1.02B |
| 79 | NUVB | Nuvation Bio Inc. | 2.45B | 48.96% | 58,820,680 | 26.75M |
| 80 | TERN | Terns Pharmaceuticals, Inc. | 2.44B | -1.60% | 4,197,504 | - |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.37B | 0.81% | 1,181,909 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.31B | 10.18% | 2,812,087 | 252.75M |
| 83 | ZLAB | Zai Lab Limited | 2.27B | 0.10% | 517,432 | 441.63M |
| 84 | GPCR | Structure Therapeutics Inc. | 2.22B | 5.83% | 3,277,962 | - |
| 85 | RCUS | Arcus Biosciences, Inc. | 2.18B | 0.15% | 1,139,982 | 240.00M |
| 86 | IBRX | ImmunityBio, Inc. | 2.11B | 1.97% | 7,696,309 | 82.56M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.10B | -3.12% | 26,932,176 | 43.69M |
| 88 | BEAM | Beam Therapeutics Inc. | 2.07B | -4.29% | 1,646,614 | 55.70M |
| 89 | GLPG | Galapagos NV | 2.01B | 0.23% | 143,303 | 336.64M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.94% | 1,760,905 | 265.81M |
| 91 | ZBIO | Zenas BioPharma, Inc. | 1.99B | 2.60% | 255,843 | 15.00M |
| 92 | VCEL | Vericel Corporation | 1.97B | -0.20% | 447,336 | 258.72M |
| 93 | IMCR | Immunocore Holdings plc | 1.95B | 1.55% | 354,548 | 379.59M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.92B | -2.00% | 926,274 | 825.94M |
| 95 | SYRE | Spyre Therapeutics, Inc. | 1.89B | 0.83% | 586,745 | - |
| 96 | MESO | Mesoblast Limited | 1.87B | -0.47% | 69,626 | 17.20M |
| 97 | VERA | Vera Therapeutics, Inc. | 1.83B | -1.25% | 1,227,020 | - |
| 98 | PHVS | Pharvaris N.V. | 1.77B | 2.38% | 703,626 | - |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.75B | -0.07% | 1,830,016 | 3.08M |
| 100 | QURE | uniQure N.V. | 1.74B | -5.92% | 1,999,575 | 15.75M |
| 101 | JANX | Janux Therapeutics, Inc. | 1.73B | -0.62% | 651,656 | 10.00M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -6.02% | 4,365,100 | 2.41B |
| 103 | SION | Sionna Therapeutics, Inc. | 1.71B | -1.81% | 185,338 | - |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.71B | 7.04% | 678,433 | 2.50M |
| 105 | ZYME | Zymeworks Inc. | 1.69B | -1.70% | 1,935,303 | 134.48M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.66B | -2.58% | 866,050 | 2.60M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.63B | -1.52% | 530,784 | 205.63M |
| 108 | IMNM | Immunome, Inc. | 1.62B | -0.95% | 1,450,187 | 9.68M |
| 109 | INVA | Innoviva, Inc. | 1.59B | -2.74% | 829,994 | 388.52M |
| 110 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.57B | 2.65% | 1,481,244 | -665.00K |
| 111 | MNKD | MannKind Corporation | 1.54B | -1.19% | 2,724,833 | 313.79M |
| 112 | PGEN | Precigen, Inc. | 1.49B | -12.99% | 5,220,631 | 6.31M |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.45B | 13.01% | 1,675,092 | 83.69M |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.45B | -2.22% | 1,931,798 | 111.30M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.42B | -2.39% | 1,899,450 | - |
| 116 | ORKA | Oruka Therapeutics, Inc. | 1.37B | 2.95% | 380,881 | - |
| 117 | ARDX | Ardelyx, Inc. | 1.35B | -4.13% | 3,278,641 | 398.23M |
| 118 | UPB | Upstream Bio, Inc. | 1.35B | -2.43% | 422,232 | 2.80M |
| 119 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | -3.53% | 18,784,511 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.31B | -2.17% | 438,911 | - |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.30B | -50.89% | 17,670,792 | 44.79M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.28B | 6.16% | 260,761 | - |
| 123 | IMTX | Immatics N.V. | 1.26B | 0.10% | 597,744 | 99.45M |
| 124 | BHVN | Biohaven Ltd. | 1.26B | 0.11% | 3,889,759 | - |
| 125 | MBX | MBX Biosciences, Inc. | 1.23B | 3.91% | 655,142 | - |
| 126 | NKTR | Nektar Therapeutics | 1.23B | 1.91% | 634,950 | 62.60M |
| 127 | INBX | Inhibrx Biosciences, Inc. | 1.19B | 5.86% | 409,640 | 1.40M |
| 128 | URGN | UroGen Pharma Ltd. | 1.18B | 7.43% | 1,013,520 | 96.52M |
| 129 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.18B | 2.29% | 1,392,495 | 42.34M |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 1.18B | 0.14% | 1,746,761 | 266.14M |
| 131 | CVAC | CureVac N.V. | 1.18B | -0.19% | 724,999 | 599.54M |
| 132 | WVE | Wave Life Sciences Ltd. | 1.15B | -3.23% | 2,144,273 | 109.23M |
| 133 | PVLA | Palvella Therapeutics, Inc. | 1.15B | 16.84% | 596,744 | - |
| 134 | XNCR | Xencor, Inc. | 1.13B | -1.56% | 665,948 | 150.13M |
| 135 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -3.53% | 637,254 | - |
| 136 | TNGX | Tango Therapeutics, Inc. | 1.12B | 3.56% | 3,435,268 | 66.50M |
| 137 | SVRA | Savara Inc. | 1.11B | 10.43% | 3,482,629 | - |
| 138 | RLAY | Relay Therapeutics, Inc. | 1.10B | -2.61% | 1,774,293 | 8.36M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.10B | -3.37% | 2,348,267 | 6.31M |
| 140 | PHAR | Pharming Group N.V. | 1.10B | 1.60% | 28,958 | 362.27M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.08B | -1.37% | 2,756,666 | 35.33M |
| 142 | MNMD | Mind Medicine (MindMed) Inc. | 1.08B | -4.21% | 1,233,315 | - |
| 143 | SEPN | Septerna, Inc. | 1.03B | 6.50% | 389,711 | 22.05M |
| 144 | KOD | Kodiak Sciences Inc. | 1.03B | 1.61% | 588,262 | - |
| 145 | PHAT | Phathom Pharmaceuticals, Inc. | 1.03B | -1.33% | 701,203 | 147.19M |
| 146 | NVAX | Novavax, Inc. | 1.03B | -3.50% | 6,654,669 | 1.06B |
| 147 | NBTX | Nanobiotix S.A. | 1.03B | -0.64% | 71,715 | 11.93M |
| 148 | ANAB | AnaptysBio, Inc. | 1.02B | - | 352,913 | 169.47M |
| 149 | OCS | Oculis Holding AG | 1.01B | -0.08% | 106,614 | 992.00K |
| 150 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.00B | -5.93% | 131,174 | - |
| 151 | KURA | Kura Oncology, Inc. | 985.04M | 2.17% | 1,632,584 | 104.03M |
| 152 | MLTX | MoonLake Immunotherapeutics | 966.40M | 1.04% | 1,469,283 | - |
| 153 | MDXG | MiMedx Group, Inc. | 958.96M | -3.65% | 910,832 | 393.44M |
| 154 | NTLA | Intellia Therapeutics, Inc. | 954.44M | -2.72% | 3,976,424 | 57.53M |
| 155 | RZLT | Rezolute, Inc. | 941.18M | -0.10% | 1,970,271 | - |
| 156 | FTRE | Fortrea Holdings Inc. | 927.70M | -1.57% | 843,423 | 2.76B |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 920.77M | 2.61% | 523,266 | 181.54M |
| 158 | SANA | Sana Biotechnology, Inc. | 905.64M | -3.68% | 2,499,268 | - |
| 159 | IOVA | Iovance Biotherapeutics, Inc. | 899.13M | -7.17% | 9,809,051 | 250.43M |
| 160 | TBPH | Theravance Biopharma, Inc. | 898.42M | -4.11% | 537,971 | 80.33M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 894.97M | -3.31% | 872,954 | 192.44M |
| 162 | GHRS | GH Research PLC | 890.12M | 4.36% | 392,053 | - |
| 163 | LENZ | LENZ Therapeutics, Inc. | 889.57M | 4.41% | 1,202,955 | 17.50M |
| 164 | TYRA | Tyra Biosciences, Inc. | 887.04M | 3.62% | 257,484 | - |
| 165 | CMPX | Compass Therapeutics, Inc. | 871.52M | -0.61% | 1,084,570 | 850.00K |
| 166 | DAWN | Day One Biopharmaceuticals, Inc. | 863.50M | -1.87% | 2,213,561 | 133.67M |
| 167 | BCAX | Bicara Therapeutics Inc. | 831.59M | -2.50% | 574,823 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 826.87M | -0.89% | 136,261 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 821.22M | -4.04% | 2,842,171 | 14.61M |
| 170 | ATAI | Atai Beckley N.V. | 818.77M | -2.80% | 3,291,681 | 3.02M |
| 171 | CRMD | CorMedix Inc. | 790.25M | -0.45% | 2,134,092 | 214.30M |
| 172 | RAPT | RAPT Therapeutics, Inc. | 785.33M | 0.21% | 279,806 | - |
| 173 | ERAS | Erasca, Inc. | 783.04M | -3.50% | 2,015,941 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 756.84M | -1.09% | 1,449,440 | 16.86M |
| 175 | RIGL | Rigel Pharmaceuticals, Inc. | 756.55M | -9.82% | 999,247 | 282.08M |
| 176 | VALN | Valneva SE | 751.10M | -0.58% | 8,931 | 230.57M |
| 177 | ARVN | Arvinas, Inc. | 740.51M | -11.24% | 3,691,579 | 312.30M |
| 178 | GOSS | Gossamer Bio, Inc. | 726.77M | 2.95% | 3,041,187 | 44.05M |
| 179 | VSTM | Verastem, Inc. | 715.48M | - | 2,297,399 | 13.38M |
| 180 | ATXS | Astria Therapeutics, Inc. | 710.14M | -0.40% | 497,908 | 706.00K |
| 181 | REPL | Replimune Group, Inc. | 705.21M | 2.86% | 1,805,291 | - |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 700.84M | 0.07% | 2,497,430 | 142.77M |
| 183 | PROK | ProKidney Corp. | 697.94M | 1.75% | 1,194,612 | 744.00K |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 692.99M | -3.92% | 1,523,734 | 1.43M |
| 185 | GERN | Geron Corporation | 689.42M | -2.70% | 7,976,689 | 183.40M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 688.04M | -1.30% | 41,648 | 107.27M |
| 187 | ALMS | Alumis Inc. | 685.86M | 2.50% | 1,611,814 | 22.12M |
| 188 | VTYX | Ventyx Biosciences, Inc. | 675.77M | -2.77% | 1,197,025 | - |
| 189 | CRVS | Corvus Pharmaceuticals, Inc. | 664.67M | -2.09% | 742,776 | - |
| 190 | LXEO | Lexeo Therapeutics, Inc. | 663.45M | -0.98% | 1,707,789 | - |
| 191 | PRME | Prime Medicine, Inc. | 658.58M | 4.79% | 5,540,605 | 5.98M |
| 192 | YDES | YD Bio Limited | 653.97M | -4.81% | 44,557 | 510.36K |
| 193 | MPLT | MapLight Therapeutics, Inc. | 632.80M | -2.49% | 212,039 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 622.90M | 18.29% | 3,860,354 | 80.00M |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 617.06M | 7.04% | 904,164 | 120.00K |
| 196 | CTMX | CytomX Therapeutics, Inc. | 615.05M | -0.82% | 1,643,010 | 113.63M |
| 197 | MGTX | MeiraGTx Holdings plc | 609.32M | -2.32% | 516,231 | 27.42M |
| 198 | ASMB | Assembly Biosciences, Inc. | 601.05M | 5.88% | 269,642 | 37.19M |
| 199 | ANNX | Annexon, Inc. | 587.60M | 26.87% | 10,549,279 | - |
| 200 | IVVD | Invivyd, Inc. | 582.81M | -1.19% | 6,434,619 | 50.04M |
| 201 | OMER | Omeros Corporation | 582.80M | -3.29% | 1,298,314 | - |
| 202 | EVMN | Evommune, Inc. | 580.20M | -4.46% | 47,904 | 3.00M |
| 203 | JBIO | Jade Biosciences, Inc. | 573.21M | -1.50% | 185,969 | - |
| 204 | IVA | Inventiva S.A. | 554.96M | -1.20% | 186,491 | 19.93M |
| 205 | MNPR | Monopar Therapeutics Inc. | 554.65M | 2.98% | 91,890 | - |
| 206 | RGNX | REGENXBIO Inc. | 553.31M | -2.84% | 585,628 | 161.32M |
| 207 | NAGE | Niagen Bioscience, Inc. | 552.62M | 0.58% | 828,766 | 124.71M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 544.96M | -0.21% | 968,056 | 84.39M |
| 209 | PRTA | Prothena Corporation plc | 537.34M | -3.65% | 475,907 | 11.79M |
| 210 | LXRX | Lexicon Pharmaceuticals, Inc. | 526.93M | -1.36% | 1,595,077 | 70.86M |
| 211 | NBP | NovaBridge Biosciences | 518.70M | -0.88% | 403,431 | - |
| 212 | KROS | Keros Therapeutics, Inc. | 514.57M | -3.76% | 1,385,238 | 246.72M |
| 213 | CGEM | Cullinan Therapeutics, Inc. | 499.19M | -1.05% | 835,520 | - |
| 214 | ADCT | ADC Therapeutics SA | 497.99M | 0.50% | 636,730 | 75.21M |
| 215 | ANRO | Alto Neuroscience, Inc. | 483.39M | 5.49% | 517,856 | - |
| 216 | ALT | Altimmune, Inc. | 478.93M | -1.29% | 4,002,513 | 20.00K |
| 217 | DBVT | DBV Technologies S.A. | 469.43M | 2.26% | 42,242 | 5.50M |
| 218 | OPT | Opthea Limited | 466.57M | 7.23% | 3,025 | 146.00K |
| 219 | IMRX | Immuneering Corporation | 462.97M | 0.28% | 772,082 | - |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 449.57M | 1.02% | 1,033,722 | 180.61M |
| 221 | DRUG | Bright Minds Biosciences Inc. | 449.40M | 0.97% | 115,275 | - |
| 222 | BNTC | Benitec Biopharma Inc. | 443.93M | -3.10% | 186,775 | - |
| 223 | ENGN | enGene Holdings Inc. | 436.55M | -1.74% | 1,749,646 | - |
| 224 | BCYC | Bicycle Therapeutics plc | 433.55M | -3.40% | 350,652 | 28.34M |
| 225 | ABSI | Absci Corporation | 430.06M | 0.70% | 3,411,594 | 2.82M |
| 226 | NMRA | Neumora Therapeutics, Inc. | 424.41M | -4.51% | 986,362 | - |
| 227 | DSGN | Design Therapeutics, Inc. | 418.11M | -3.29% | 223,320 | - |
| 228 | LCTX | Lineage Cell Therapeutics, Inc. | 414.38M | -3.39% | 1,134,198 | 10.82M |
| 229 | XOMA | XOMA Royalty Corporation | 410.50M | 1.10% | 90,713 | 47.11M |
| 230 | LBRX | LB Pharmaceuticals Inc | 401.62M | -0.28% | 91,158 | - |
| 231 | VTVT | vTv Therapeutics Inc. | 400.06M | 7.07% | 21,295 | 17.00K |
| 232 | PRTC | PureTech Health plc | 392.51M | 0.76% | 1,087 | 6.39M |
| 233 | PEPG | PepGen Inc. | 380.18M | -3.66% | 856,205 | - |
| 234 | DMAC | DiaMedica Therapeutics Inc. | 380.17M | 5.80% | 811,165 | - |
| 235 | GALT | Galectin Therapeutics Inc. | 370.11M | -7.27% | 262,898 | - |
| 236 | LYEL | Lyell Immunopharma, Inc. | 365.38M | -3.96% | 22,209 | 41.00K |
| 237 | CTNM | Contineum Therapeutics, Inc. | 362.74M | 7.99% | 135,052 | - |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 360.44M | 5.11% | 747,683 | - |
| 239 | OCGN | Ocugen, Inc. | 354.48M | -1.30% | 2,252,048 | 5.37M |
| 240 | TECX | Tectonic Therapeutic, Inc. | 351.12M | 2.63% | 467,265 | - |
| 241 | SLDB | Solid Biosciences Inc. | 349.04M | 0.22% | 1,065,469 | - |
| 242 | AURA | Aura Biosciences, Inc. | 342.92M | -0.18% | 173,437 | - |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 338.58M | -1.74% | 248,781 | 65.32M |
| 244 | AUTL | Autolus Therapeutics plc | 338.00M | -1.55% | 1,464,089 | 51.13M |
| 245 | FBRX | Forte Biosciences, Inc. | 337.93M | 5.45% | 267,686 | - |
| 246 | CLLS | Cellectis S.A. | 325.83M | 7.06% | 130,639 | 82.55M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 325.51M | -2.67% | 62,555 | - |
| 248 | NGNE | Neurogene Inc. | 325.13M | -1.73% | 130,115 | 925.00K |
| 249 | PALI | Palisade Bio, Inc. | 323.34M | 4.83% | 4,972,115 | - |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 319.14M | 1.39% | 565,682 | 33.98M |
| 251 | AVTX | Avalo Therapeutics, Inc. | 318.98M | -2.28% | 220,256 | 192.00K |
| 252 | TRDA | Entrada Therapeutics, Inc. | 313.07M | -1.02% | 330,709 | 61.52M |
| 253 | DRTS | Alpha Tau Medical Ltd. | 312.96M | - | 20,566 | - |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 310.60M | -2.38% | 3,069,937 | - |
| 255 | AVXL | Anavex Life Sciences Corp. | 309.22M | 2.86% | 2,201,392 | - |
| 256 | RLMD | Relmada Therapeutics, Inc. | 308.73M | -1.41% | 2,461,374 | - |
| 257 | ACIU | AC Immune SA | 308.70M | 2.30% | 129,120 | 5.48M |
| 258 | NAUT | Nautilus Biotechnology, Inc. | 304.40M | 9.05% | 885,611 | - |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 303.76M | -3.93% | 1,764,850 | 212.07M |
| 260 | SLN | Silence Therapeutics plc | 303.71M | -4.74% | 294,251 | 25.83M |
| 261 | TENX | Tenax Therapeutics, Inc. | 297.79M | -4.49% | 34,485 | - |
| 262 | CYBN | Cybin Inc. | 295.93M | -1.50% | 804,846 | - |
| 263 | LRMR | Larimar Therapeutics, Inc. | 295.71M | 1.92% | 2,613,704 | - |
| 264 | ALDX | Aldeyra Therapeutics, Inc. | 292.39M | -1.02% | 502,735 | - |
| 265 | MREO | Mereo BioPharma Group plc | 288.03M | -0.55% | 1,465,766 | 500.00K |
| 266 | PYXS | Pyxis Oncology, Inc. | 285.17M | -2.97% | 355,701 | 2.82M |
| 267 | ALLO | Allogene Therapeutics, Inc. | 283.16M | -3.82% | 2,208,821 | 22.00K |
| 268 | FHTX | Foghorn Therapeutics Inc. | 274.84M | -3.19% | 126,991 | 24.52M |
| 269 | FENC | Fennec Pharmaceuticals Inc. | 268.17M | -6.51% | 143,558 | 38.79M |
| 270 | ACRS | Aclaris Therapeutics, Inc. | 266.53M | -1.20% | 771,084 | 15.74M |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 265.21M | 6.10% | 69,241 | 5.05M |
| 272 | CAPR | Capricor Therapeutics, Inc. | 263.80M | 2.30% | 838,356 | 11.13M |
| 273 | OBIO | Orchestra BioMed Holdings, Inc. | 263.13M | 10.17% | 567,222 | 2.82M |
| 274 | MCRB | Seres Therapeutics, Inc. | 259.41M | 16.05% | 952,311 | 351.00K |
| 275 | TARA | Protara Therapeutics, Inc. | 258.53M | -0.74% | 1,481,060 | - |
| 276 | SGMT | Sagimet Biosciences Inc. | 255.94M | 0.64% | 309,666 | - |
| 277 | CBIO | Crescent Biopharma, Inc. | 254.73M | 0.23% | 39,282 | - |
| 278 | ZURA | Zura Bio Limited | 251.64M | 1.04% | 440,652 | - |
| 279 | IMMP | Immutep Limited | 248.70M | -2.29% | 163,622 | 3.31M |
| 280 | PBYI | Puma Biotechnology, Inc. | 246.16M | -3.46% | 306,928 | 212.00M |
| 281 | AVIR | Atea Pharmaceuticals, Inc. | 246.10M | 3.28% | 382,606 | - |
| 282 | EDIT | Editas Medicine, Inc. | 245.51M | -4.01% | 1,168,991 | 46.38M |
| 283 | CADL | Candel Therapeutics, Inc. | 242.92M | -4.22% | 516,806 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 242.29M | 0.81% | 1,100,915 | 30.11M |
| 285 | OABI | OmniAb, Inc. | 237.53M | 2.48% | 395,678 | 21.09M |
| 286 | MIST | Milestone Pharmaceuticals Inc. | 236.69M | -3.32% | 2,903,590 | - |
| 287 | VYGR | Voyager Therapeutics, Inc. | 231.30M | -2.80% | 405,581 | 31.32M |
| 288 | ACHV | Achieve Life Sciences, Inc. | 229.97M | -0.23% | 387,928 | - |
| 289 | MDWD | MediWound Ltd. | 228.99M | -2.30% | 97,416 | 19.86M |
| 290 | ABEO | Abeona Therapeutics Inc. | 228.15M | -6.03% | 2,074,289 | 400.00K |
| 291 | AARD | Aardvark Therapeutics, Inc. | 227.75M | 6.30% | 176,027 | - |
| 292 | GNFT | Genfit S.A. | 223.01M | 2.54% | 55,983 | 52.99M |
| 293 | BDTX | Black Diamond Therapeutics, Inc. | 221.63M | -2.02% | 679,705 | 70.00M |
| 294 | HUMA | Humacyte, Inc. | 219.11M | -2.50% | 4,681,496 | 1.57M |
| 295 | SLS | SELLAS Life Sciences Group, Inc. | 217.94M | -3.77% | 2,512,724 | - |
| 296 | CABA | Cabaletta Bio, Inc. | 215.63M | -4.27% | 1,812,749 | - |
| 297 | PRQR | ProQR Therapeutics N.V. | 213.85M | -2.40% | 146,391 | 18.86M |
| 298 | RANI | Rani Therapeutics Holdings, Inc. | 212.65M | -5.91% | 2,507,234 | 1.20M |
| 299 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 207.48M | -1.58% | 292,480 | - |
| 300 | TLSA | Tiziana Life Sciences Ltd | 200.81M | -4.52% | 101,898 | - |
| 301 | HRTX | Heron Therapeutics, Inc. | 199.87M | -2.68% | 4,091,867 | 155.10M |
| 302 | TNYA | Tenaya Therapeutics, Inc. | 198.14M | -7.03% | 1,990,451 | - |
| 303 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.02M | 2.58% | 1,360,052 | 10.30M |
| 304 | GNLX | Genelux Corporation | 188.09M | -1.19% | 134,998 | 8.00K |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 185.93M | -6.17% | 101,809 | 1.09M |
| 306 | VTGN | Vistagen Therapeutics, Inc. | 177.73M | -2.81% | 723,228 | 721.00K |
| 307 | CNTB | Connect Biopharma Holdings Limited | 176.10M | 22.57% | 1,849,145 | 762.00K |
| 308 | GUTS | Fractyl Health, Inc. | 175.82M | -5.00% | 1,658,592 | 3.00K |
| 309 | ETHZ | ETHZilla Corporation | 175.30M | -11.93% | 1,284,775 | 4.11M |
| 310 | CAMP | Camp4 Therapeutics Corporation | 174.87M | -5.57% | 44,341 | 3.80M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 171.61M | -8.76% | 1,025,115 | 97.60M |
| 312 | CRBU | Caribou Biosciences, Inc. | 170.11M | -2.67% | 914,728 | 9.30M |
| 313 | IPHA | Innate Pharma S.A. | 165.38M | 0.56% | 13,602 | 14.84M |
| 314 | VOR | Vor Biopharma Inc. | 159.61M | -14.25% | 785,190 | - |
| 315 | MOLN | Molecular Partners AG | 154.57M | 1.70% | 1,190 | 856.30K |
| 316 | NVCT | Nuvectis Pharma, Inc. | 152.92M | -1.32% | 122,074 | - |
| 317 | CGEN | Compugen Ltd. | 149.66M | -1.23% | 308,335 | 6.90M |
| 318 | CDXS | Codexis, Inc. | 146.33M | -1.22% | 907,304 | 52.93M |
| 319 | ANIX | Anixa Biosciences, Inc. | 143.19M | 6.10% | 153,301 | - |
| 320 | AGEN | Agenus Inc. | 142.84M | -0.71% | 267,920 | 106.83M |
| 321 | IMMX | Immix Biopharma, Inc. | 142.37M | -0.24% | 643,770 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 142.35M | -5.85% | 484,066 | 61.84M |
| 323 | ELTX | Elicio Therapeutics, Inc. | 141.55M | -5.48% | 176,343 | - |
| 324 | CHRS | Coherus Oncology, Inc. | 140.81M | -3.72% | 615,241 | 277.73M |
| 325 | MRSN | Mersana Therapeutics, Inc. | 137.79M | 0.25% | 89,369 | 33.18M |
| 326 | PRLD | Prelude Therapeutics Incorporated | 137.60M | -0.60% | 235,652 | 10.50M |
| 327 | ACTU | Actuate Therapeutics, Inc. | 135.97M | -4.10% | 18,959 | - |
| 328 | CRDF | Cardiff Oncology, Inc. | 134.72M | -1.96% | 825,218 | 501.00K |
| 329 | SPRO | Spero Therapeutics, Inc. | 133.94M | -3.64% | 511,498 | 40.55M |
| 330 | EXOZ | eXoZymes, Inc. | 133.36M | 9.50% | 1,359 | -700.00 |
| 331 | ALEC | Alector, Inc. | 133.16M | -3.94% | 1,521,428 | 69.05M |
| 332 | SAVA | Cassava Sciences, Inc. | 132.85M | -1.43% | 646,769 | - |
| 333 | SGMO | Sangamo Therapeutics, Inc. | 131.94M | -6.93% | 6,284,593 | 32.88M |
| 334 | NTHI | NeOnc Technologies Holdings, Inc. | 128.94M | -4.67% | 46,841 | 59.99K |
| 335 | NBY | NovaBay Pharmaceuticals, Inc. | 128.53M | -5.56% | 137,692 | 10.30M |
| 336 | IRD | Opus Genetics, Inc. | 128.27M | -1.06% | 460,296 | 14.63M |
| 337 | NKTX | Nkarta, Inc. | 127.14M | -1.10% | 638,006 | - |
| 338 | CLYM | Climb Bio, Inc. | 125.46M | -3.66% | 228,226 | - |
| 339 | KLRS | Kalaris Therapeutics, Inc. | 124.93M | 3.57% | 469,360 | - |
| 340 | STTK | Shattuck Labs, Inc. | 124.03M | -2.49% | 80,015 | 1.00M |
| 341 | ACOG | Alpha Cognition Inc. | 123.74M | -4.98% | 36,844 | 7.43M |
| 342 | CNTX | Context Therapeutics Inc. | 123.68M | 7.44% | 214,020 | - |
| 343 | CGTX | Cognition Therapeutics, Inc. | 123.58M | -7.89% | 1,618,691 | - |
| 344 | INO | Inovio Pharmaceuticals, Inc. | 122.29M | -5.82% | 1,559,449 | 182.34K |
| 345 | COYA | Coya Therapeutics, Inc. | 121.15M | -6.01% | 405,253 | 3.99M |
| 346 | FATE | Fate Therapeutics, Inc. | 121.12M | 2.94% | 1,535,023 | 7.14M |
| 347 | ENTX | Entera Bio Ltd. | 121.01M | 1.92% | 21,241 | 124.00K |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 118.85M | -6.59% | 427,542 | - |
| 349 | SPRB | Spruce Biosciences, Inc. | 118.81M | -3.48% | 338,169 | 697.00K |
| 350 | IKT | Inhibikase Therapeutics, Inc. | 118.03M | -1.88% | 41,534 | 1.00 |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 116.48M | 0.65% | 4,552,688 | - |
| 352 | DTIL | Precision BioSciences, Inc. | 116.27M | -7.47% | 388,073 | 698.00K |
| 353 | SRZN | Surrozen, Inc. | 115.71M | 4.25% | 38,683 | 3.60M |
| 354 | GLSI | Greenwich LifeSciences, Inc. | 112.78M | -1.21% | 40,968 | - |
| 355 | SEER | Seer, Inc. | 111.58M | 1.01% | 421,308 | 16.38M |
| 356 | ONCY | Oncolytics Biotech Inc. | 110.39M | 0.97% | 791,395 | - |
| 357 | QNCX | Quince Therapeutics, Inc. | 107.47M | 1.05% | 701,410 | - |
| 358 | KPTI | Karyopharm Therapeutics Inc. | 102.22M | -3.93% | 220,067 | 142.53M |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 100.40M | 1.81% | 14,495 | 23.93M |
| 360 | VANI | Vivani Medical, Inc. | 99.94M | -2.84% | 169,469 | - |
| 361 | ORMP | Oramed Pharmaceuticals Inc. | 99.90M | 0.80% | 347,560 | 2.00M |
| 362 | ATOS | Atossa Therapeutics, Inc. | 99.19M | -2.80% | 439,050 | - |
| 363 | GANX | Gain Therapeutics, Inc. | 99.09M | -3.68% | 535,020 | - |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 99.07M | 2.08% | 39,535 | 151.93M |
| 365 | WHWK | Whitehawk Therapeutics, Inc. | 98.03M | -2.80% | 174,425 | 14.38M |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 96.45M | -1.84% | 357,883 | 26.87M |
| 367 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.49M | -1.29% | 8,601 | - |
| 368 | CSBR | Champions Oncology, Inc. | 94.45M | - | 7,377 | 56.88M |
| 369 | ABOS | Acumen Pharmaceuticals, Inc. | 93.89M | -6.63% | 132,697 | - |
| 370 | ADVM | Adverum Biotechnologies, Inc. | 93.72M | -0.12% | 229,938 | 1.00M |
| 371 | ACET | Adicet Bio, Inc. | 93.33M | -3.99% | 1,462,423 | - |
| 372 | VXRT | Vaxart, Inc. | 93.00M | -1.52% | 283,579 | 148.20M |
| 373 | RPTX | Repare Therapeutics Inc. | 92.58M | -3.36% | 1,395,636 | 11.87M |
| 374 | PLRX | Pliant Therapeutics, Inc. | 92.17M | -4.46% | 1,262,612 | - |
| 375 | PTHS | Pelthos Therapeutics Inc. | 91.88M | -5.70% | 37,849 | 7.41M |
| 376 | OVID | Ovid Therapeutics Inc. | 91.15M | -3.03% | 690,420 | 6.61M |
| 377 | MGNX | MacroGenics, Inc. | 89.83M | -7.79% | 731,706 | 127.63M |
| 378 | HURA | TuHURA Biosciences, Inc. | 89.70M | -9.33% | 251,021 | - |
| 379 | ANVS | Annovis Bio, Inc. | 89.58M | 0.30% | 2,382,724 | - |
| 380 | TVGN | Tevogen Bio Holdings Inc. | 89.29M | 9.85% | 326,455 | - |
| 381 | THAR | Tharimmune, Inc. | 87.26M | -5.68% | 364,122 | - |
| 382 | OTLK | Outlook Therapeutics, Inc. | 87.06M | 2.62% | 3,301,518 | 1.51M |
| 383 | IMUX | Immunic, Inc. | 85.80M | -6.14% | 1,010,680 | - |
| 384 | IFRX | InflaRx N.V. | 85.36M | -0.79% | 1,031,254 | 73.73K |
| 385 | ADAG | Adagene Inc. | 85.31M | -8.74% | 36,550 | 103.20K |
| 386 | ARTV | Artiva Biotherapeutics, Inc. | 83.45M | -12.60% | 164,884 | 251.00K |
| 387 | HYFT | MindWalk Holdings Corp. | 82.85M | 1.99% | 565,543 | 18.21M |
| 388 | TIL | Instil Bio, Inc. | 82.74M | -6.15% | 49,449 | - |
| 389 | CRVO | CervoMed Inc. | 79.71M | 3.80% | 136,049 | 6.16M |
| 390 | ALXO | ALX Oncology Holdings Inc. | 79.70M | -9.82% | 286,882 | - |
| 391 | TTRX | Turn Therapeutics Inc. | 79.30M | -4.71% | 234,638 | - |
| 392 | BYSI | BeyondSpring Inc. | 78.65M | - | 16,155 | 1.88M |
| 393 | IMA | ImageneBio, Inc. | 78.07M | -3.93% | 44,811 | 800.00K |
| 394 | BMEA | Biomea Fusion, Inc. | 77.77M | -6.78% | 1,413,965 | - |
| 395 | STRO | Sutro Biopharma, Inc. | 77.47M | 2.25% | 588,730 | 105.65M |
| 396 | FBIO | Fortress Biotech, Inc. | 77.36M | -2.62% | 324,652 | 62.30M |
| 397 | COEP | Coeptis Therapeutics Holdings, Inc. | 76.93M | -6.12% | 34,401 | 501.00K |
| 398 | OKYO | OKYO Pharma Limited | 75.97M | -5.16% | 128,056 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 74.24M | -2.88% | 288,694 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 72.37M | -2.86% | 179,470 | - |
| 401 | MNOV | MediciNova, Inc. | 70.14M | -0.69% | 71,891 | 257.92K |
| 402 | CBUS | Cibus, Inc. | 69.09M | -2.31% | 176,723 | 3.79M |
| 403 | BCAB | BioAtla, Inc. | 68.20M | -4.92% | 4,829,272 | 11.00M |
| 404 | PSTV | Plus Therapeutics, Inc. | 67.35M | -3.92% | 2,761,113 | 5.26M |
| 405 | ATYR | aTyr Pharma, Inc. | 66.16M | -3.68% | 4,520,593 | 190.00K |
| 406 | ESLA | Estrella Immunopharma, Inc. | 66.09M | -3.85% | 189,391 | - |
| 407 | XBIT | XBiotech Inc. | 65.85M | -8.09% | 71,431 | - |
| 408 | LITS | Lite Strategy, Inc. | 65.48M | -7.77% | 885,277 | - |
| 409 | ABVC | ABVC BioPharma, Inc. | 64.11M | -6.85% | 68,094 | 797.92K |
| 410 | ATHE | Alterity Therapeutics Limited | 63.61M | 0.83% | 7,363 | 3.57M |
| 411 | NTRB | Nutriband Inc. | 62.12M | 1.17% | 9,950 | 2.58M |
| 412 | EQ | Equillium, Inc. | 61.50M | 1.00% | 159,731 | 4.39M |
| 413 | MGX | Metagenomi, Inc. | 60.45M | -5.29% | 297,586 | 30.91M |
| 414 | KRRO | Korro Bio, Inc. | 60.27M | 2.89% | 555,358 | 7.37M |
| 415 | PYPD | PolyPid Ltd. | 60.05M | -0.82% | 60,477 | - |
| 416 | TCRX | TScan Therapeutics, Inc. | 57.88M | 3.02% | 920,856 | 8.42M |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 57.31M | -6.32% | 2,703,575 | - |
| 418 | ANL | Adlai Nortye Ltd. | 55.72M | -3.82% | 7,256 | 1.94M |
| 419 | OSTX | OS Therapies Incorporated | 54.99M | -5.20% | 234,886 | - |
| 420 | JSPR | Jasper Therapeutics, Inc. | 51.77M | 1.09% | 282,815 | - |
| 421 | ALGS | Aligos Therapeutics, Inc. | 50.71M | 4.04% | 89,362 | 2.65M |
| 422 | NRXP | NRx Pharmaceuticals, Inc. | 50.63M | -6.58% | 496,019 | 242.00K |
| 423 | CVM | CEL-SCI Corporation | 49.72M | -7.03% | 74,850 | - |
| 424 | IOBT | IO Biotech, Inc. | 49.52M | -8.90% | 320,533 | - |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 49.16M | - | 157,460 | - |
| 426 | INKT | MiNK Therapeutics, Inc. | 49.03M | -4.16% | 12,948 | - |
| 427 | LVTX | LAVA Therapeutics N.V. | 47.61M | 1.69% | 327,313 | 4.99M |
| 428 | CALC | CalciMedica, Inc. | 46.97M | 6.19% | 83,789 | - |
| 429 | SNTI | Senti Biosciences, Inc. | 46.04M | 2.92% | 114,295 | - |
| 430 | IBO | Impact BioMedical Inc. | 45.94M | -0.45% | 112,465 | 25.00K |
| 431 | CUE | Cue Biopharma, Inc. | 45.68M | 0.03% | 130,137 | 7.10M |
| 432 | JUNS | Jupiter Neurosciences, Inc. | 45.63M | 4.80% | 46,099 | - |
| 433 | KZR | Kezar Life Sciences, Inc. | 45.40M | -0.16% | 14,865 | - |
| 434 | IPSC | Century Therapeutics, Inc. | 45.13M | 5.49% | 885,267 | 113.34M |
| 435 | CELU | Celularity Inc. | 45.11M | -2.87% | 25,408 | 40.58M |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 44.93M | 1.15% | 443,826 | 1.14M |
| 437 | GRCE | Grace Therapeutics, Inc. | 44.08M | -1.27% | 69,320 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 42.43M | -4.90% | 120,404 | 90.00K |
| 439 | XLO | Xilio Therapeutics, Inc. | 42.37M | 7.60% | 583,083 | 31.80M |
| 440 | VRCA | Verrica Pharmaceuticals Inc. | 42.32M | 16.97% | 273,280 | 30.83M |
| 441 | ICCC | ImmuCell Corporation | 42.24M | 2.41% | 15,126 | 27.77M |
| 442 | SKYE | Skye Bioscience, Inc. | 42.00M | -1.50% | 133,485 | - |
| 443 | APLT | Applied Therapeutics, Inc. | 41.04M | -4.49% | 15,865,691 | 1.00M |
| 444 | SER | Serina Therapeutics, Inc. | 40.72M | 2.77% | 25,517 | 130.00K |
| 445 | EVAX | Evaxion A/S | 40.43M | -7.41% | 133,276 | 7.65M |
| 446 | INMB | INmune Bio, Inc. | 40.14M | 0.67% | 217,382 | 50.00K |
| 447 | SABS | SAB Biotherapeutics, Inc. | 39.87M | -2.05% | 224,592 | 114.70K |
| 448 | RADX | Radiopharm Theranostics Limited | 39.75M | 7.44% | 7,106 | 8.20M |
| 449 | PDSB | PDS Biotechnology Corporation | 39.57M | -4.93% | 498,543 | - |
| 450 | APLM | Apollomics, Inc. | 38.37M | -2.51% | 7,073 | 198.00K |
| 451 | VERU | Veru Inc. | 38.36M | -5.53% | 183,776 | 16.89M |
| 452 | BTAI | BioXcel Therapeutics, Inc. | 38.05M | -5.43% | 540,439 | 752.00K |
| 453 | OKUR | OnKure Therapeutics, Inc. | 37.39M | -5.80% | 63,565 | - |
| 454 | LTRN | Lantern Pharma Inc. | 36.91M | 2.80% | 52,251 | - |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 36.87M | -4.61% | 59,109 | - |
| 456 | MURA | Mural Oncology plc | 36.12M | -0.71% | 97,977 | - |
| 457 | FGEN | FibroGen, Inc. | 34.91M | 0.35% | 26,571 | 8.30M |
| 458 | GBIO | Generation Bio Co. | 34.90M | -1.33% | 33,054 | 15.27M |
| 459 | LNAI | Lunai Bioworks Inc. | 34.77M | 29.31% | 1,397,585 | - |
| 460 | MAIA | MAIA Biotechnology, Inc. | 34.07M | -8.91% | 238,504 | - |
| 461 | GNTA | Genenta Science S.p.A. | 33.89M | -11.06% | 114,068 | - |
| 462 | DYAI | Dyadic International, Inc. | 33.59M | 2.92% | 160,977 | 3.34M |
| 463 | KLTO | Klotho Neurosciences, Inc. | 32.95M | -3.67% | 372,581 | - |
| 464 | HYPD | Hyperion DeFi, Inc. | 32.92M | -4.83% | 310,313 | 345.32K |
| 465 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 30.79M | -7.77% | 642,812 | 1.00M |
| 466 | LIMN | Liminatus Pharma, Inc. | 30.31M | 0.90% | 87,164 | - |
| 467 | XCUR | Exicure, Inc. | 30.21M | 27.11% | 62,312 | 500.00K |
| 468 | IGC | IGC Pharma, Inc. | 29.98M | -2.69% | 347,574 | 1.11M |
| 469 | BRNS | Barinthus Biotherapeutics plc | 29.81M | 2.37% | 77,456 | 14.97M |
| 470 | NERV | Minerva Neurosciences, Inc. | 29.79M | -0.93% | 38,614 | - |
| 471 | ANTX | AN2 Therapeutics, Inc. | 29.59M | -3.57% | 22,425 | - |
| 472 | RNTX | Rein Therapeutics Inc. | 29.36M | 3.28% | 138,645 | - |
| 473 | PLUR | Pluri Inc. | 29.12M | -2.23% | 22,729 | 1.33M |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 27.42M | -11.69% | 483,178 | - |
| 475 | NNVC | NanoViricides, Inc. | 27.26M | 1.81% | 446,358 | - |
| 476 | QNTM | Quantum BioPharma Ltd. | 27.26M | -7.07% | 93,400 | - |
| 477 | CLGN | CollPlant Biotechnologies Ltd. | 27.21M | -0.47% | 25,851 | 2.40M |
| 478 | NRXS | NeurAxis, Inc. | 27.06M | 5.83% | 111,341 | 3.36M |
| 479 | GLTO | Galecto, Inc. | 26.98M | -2.59% | 176,628 | - |
| 480 | RNXT | RenovoRx, Inc. | 26.87M | -6.28% | 196,039 | 928.00K |
| 481 | RLYB | Rallybio Corporation | 26.37M | -0.35% | 91,742 | 674.00K |
| 482 | QTTB | Q32 Bio Inc. | 26.09M | -7.02% | 55,978 | - |
| 483 | BOLD | Boundless Bio, Inc. | 25.74M | -3.36% | 90,654 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 25.67M | -0.60% | 1,097,136 | - |
| 485 | NXTC | NextCure, Inc. | 25.08M | -6.40% | 9,700 | - |
| 486 | PASG | Passage Bio, Inc. | 25.05M | -7.51% | 58,369 | - |
| 487 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.76M | - | 69,818 | - |
| 488 | IBIO | iBio, Inc. | 24.51M | -9.92% | 1,210,574 | 500.00K |
| 489 | LEXX | Lexaria Bioscience Corp. | 24.46M | 4.76% | 225,947 | 615.92K |
| 490 | DARE | Daré Bioscience, Inc. | 24.43M | -3.93% | 217,986 | -57.13K |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 23.37M | -5.61% | 14,410 | - |
| 492 | ENLV | Enlivex Therapeutics Ltd. | 22.80M | -4.07% | 174,503 | - |
| 493 | PMN | ProMIS Neurosciences, Inc. | 22.35M | 14.38% | 1,799,229 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 21.69M | 4.33% | 818,899 | - |
| 495 | TPST | Tempest Therapeutics, Inc. | 21.09M | -48.59% | 945,879 | - |
| 496 | GDTC | CytoMed Therapeutics Limited | 20.89M | -8.12% | 59,935 | 573.19K |
| 497 | APVO | Aptevo Therapeutics Inc. | 20.56M | -7.58% | 646,928 | - |
| 498 | ATHA | Athira Pharma, Inc. | 19.21M | 5.87% | 54,477 | - |
| 499 | CING | Cingulate Inc. | 19.17M | 1.18% | 44,323 | - |
| 500 | SYBX | Synlogic, Inc. | 18.95M | -1.82% | 3,745 | 8.00K |
| 501 | MTVA | MetaVia Inc. | 18.78M | -4.64% | 197,269 | - |
| 502 | ITRM | Iterum Therapeutics plc | 18.50M | -2.75% | 793,452 | 390.00K |
| 503 | CTXR | Citius Pharmaceuticals, Inc. | 18.47M | -6.54% | 202,423 | - |
| 504 | CASI | CASI Pharmaceuticals, Inc. | 18.33M | -2.23% | 15,523 | 26.85M |
| 505 | LSTA | Lisata Therapeutics, Inc. | 17.91M | -0.98% | 35,462 | 1.07M |
| 506 | HOTH | Hoth Therapeutics, Inc. | 17.84M | -2.54% | 132,690 | - |
| 507 | AKTX | Akari Therapeutics, Plc | 17.82M | -6.03% | 94,162 | - |
| 508 | FBLG | FibroBiologics, Inc. | 17.73M | 4.30% | 2,863,716 | - |
| 509 | LPCN | Lipocine Inc. | 17.71M | -5.62% | 68,952 | 4.32M |
| 510 | TRAW | Traws Pharma, Inc. | 16.86M | -0.94% | 77,369 | 2.85M |
| 511 | PULM | Pulmatrix, Inc. | 16.62M | 1.11% | 5,196 | 3.00K |
| 512 | ABP | Abpro Holdings, Inc. | 16.40M | 0.16% | 23,244 | 183.00K |
| 513 | PCSA | Processa Pharmaceuticals, Inc. | 15.78M | -8.95% | 1,738,488 | - |
| 514 | CANF | Can-Fite BioPharma Ltd. | 15.61M | -12.13% | 11,728,724 | 560.00K |
| 515 | ALLR | Allarity Therapeutics, Inc. | 15.54M | -6.14% | 350,776 | - |
| 516 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.25M | -5.51% | 130,215 | - |
| 517 | NCEL | NewcelX Ltd. | 15.13M | -2.35% | 24,330 | - |
| 518 | CLSD | Clearside Biomedical, Inc. | 14.97M | -6.84% | 62,448 | 3.33M |
| 519 | KAPA | Kairos Pharma, Ltd. | 14.81M | -4.83% | 117,841 | - |
| 520 | CRIS | Curis, Inc. | 14.61M | -8.13% | 135,076 | 11.65M |
| 521 | BCTX | BriaCell Therapeutics Corp. | 14.50M | -8.19% | 39,398 | - |
| 522 | BLRX | BioLineRx Ltd. | 14.32M | 3.74% | 41,929 | 17.25M |
| 523 | KZIA | Kazia Therapeutics Limited | 14.20M | 34.38% | 26,908,139 | 1.20M |
| 524 | MRKR | Marker Therapeutics, Inc. | 14.10M | 7.92% | 572,136 | 4.69M |
| 525 | BCDA | BioCardia, Inc. | 14.01M | 2.33% | 38,423 | 3.00K |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 13.97M | -1.10% | 92,548 | - |
| 527 | DWTX | Dogwood Therapeutics, Inc. | 13.69M | -2.93% | 37,016 | - |
| 528 | SNGX | Soligenix, Inc. | 13.31M | -3.65% | 553,823 | 2.34K |
| 529 | APM | Aptorum Group Limited | 13.19M | 3.85% | 247,487 | - |
| 530 | LGVN | Longeveron Inc. | 13.11M | -3.97% | 532,891 | 1.44M |
| 531 | COCP | Cocrystal Pharma, Inc. | 12.91M | -2.93% | 45,322 | - |
| 532 | BRTX | BioRestorative Therapies, Inc. | 12.69M | 15.32% | 330,141 | 383.40K |
| 533 | SNSE | Sensei Biotherapeutics, Inc. | 12.63M | 17.29% | 78,308 | - |
| 534 | GOVX | GeoVax Labs, Inc. | 12.32M | 1.67% | 335,489 | 3.35M |
| 535 | EDSA | Edesa Biotech, Inc. | 12.18M | -0.57% | 12,118 | - |
| 536 | CLRB | Cellectar Biosciences, Inc. | 12.13M | -6.84% | 47,266 | - |
| 537 | VYNE | VYNE Therapeutics Inc. | 11.99M | -5.38% | 607,898 | 524.00K |
| 538 | IMNN | Imunon, Inc. | 11.61M | -7.58% | 39,249 | - |
| 539 | IMRN | Immuron Limited | 11.13M | -1.92% | 45,925 | 4.78M |
| 540 | AEON | AEON Biopharma, Inc. | 10.95M | -2.14% | 167,237 | - |
| 541 | PPCB | Propanc Biopharma, Inc. | 10.89M | 3.66% | 38,256 | - |
| 542 | CELZ | Creative Medical Technology Holdings, Inc. | 10.76M | -4.59% | 142,565 | 6.00K |
| 543 | ERNA | Ernexa Therapeutics Inc. | 10.75M | -7.43% | 49,606 | 1,000.00 |
| 544 | OSRH | OSR Holdings, Inc. | 10.61M | -1.88% | 110,619 | -90.52K |
| 545 | ICU | SeaStar Medical Holding Corporation | 10.61M | -7.13% | 787,800 | 881.00K |
| 546 | NEUP | Neuphoria Therapeutics Inc. | 10.42M | -6.75% | 100,033 | 15.65M |
| 547 | ADXN | Addex Therapeutics Ltd | 10.37M | -5.47% | 1,366 | 210.35K |
| 548 | BIVI | BioVie Inc. | 10.33M | -4.20% | 85,619 | - |
| 549 | EVGN | Evogene Ltd. | 10.30M | -3.25% | 61,187 | 9.44M |
| 550 | BOLT | Bolt Biotherapeutics, Inc. | 8.98M | 1.41% | 24,889 | 5.20M |
| 551 | ALZN | Alzamend Neuro, Inc. | 8.78M | -5.33% | 724,591 | - |
| 552 | MBIO | Mustang Bio, Inc. | 8.76M | -2.44% | 122,199 | - |
| 553 | XTLB | XTL Biopharmaceuticals Ltd. | 8.60M | -4.19% | 18,817 | 451.00K |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 8.34M | -7.83% | 54,030 | - |
| 555 | PLRZ | Polyrizon Ltd. | 8.31M | -6.70% | 99,151 | - |
| 556 | TOVX | Theriva Biologics, Inc. | 7.77M | -8.10% | 1,975,668 | - |
| 557 | ADIL | Adial Pharmaceuticals, Inc. | 7.60M | 2.00% | 211,722 | - |
| 558 | APRE | Aprea Therapeutics, Inc. | 7.57M | 0.84% | 44,217 | 488.24K |
| 559 | INAB | IN8bio, Inc. | 7.51M | -1.22% | 34,899 | - |
| 560 | RNAZ | TransCode Therapeutics, Inc. | 7.49M | -0.44% | 10,163 | - |
| 561 | TCRT | Alaunos Therapeutics, Inc. | 7.39M | -0.90% | 28,092 | 6.00K |
| 562 | PHIO | Phio Pharmaceuticals Corp. | 7.16M | -1.57% | 414,807 | - |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 7.08M | -6.76% | 49,054 | 20.00K |
| 564 | PHGE | BiomX Inc. | 7.01M | -6.65% | 1,032,944 | - |
| 565 | ENSC | Ensysce Biosciences, Inc. | 6.48M | -5.18% | 98,684 | 4.49M |
| 566 | NCNA | NuCana plc | 6.41M | 1.51% | 32,466 | - |
| 567 | PTN | Palatin Technologies, Inc. | 6.33M | 1.81% | 42,718 | 8.85M |
| 568 | PPBT | Purple Biotech Ltd | 6.06M | -4.67% | 164,471 | - |
| 569 | XBIO | Xenetic Biosciences, Inc. | 5.82M | -1.17% | 206,413 | 2.86M |
| 570 | CLDI | Calidi Biotherapeutics, Inc. | 5.80M | -3.36% | 173,694 | - |
| 571 | LYRA | Lyra Therapeutics, Inc. | 5.71M | -4.93% | 13,706 | 600.00K |
| 572 | VIVS | VivoSim Labs, Inc. | 5.58M | -4.46% | 12,026 | 140.00K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.44M | 0.70% | 31,423 | 2.86M |
| 574 | SILO | Silo Pharma, Inc. | 5.26M | -5.73% | 96,815 | 72.10K |
| 575 | PBM | Psyence Biomedical Ltd. | 5.22M | - | 9,055 | - |
| 576 | MTNB | Matinas BioPharma Holdings, Inc. | 5.18M | -31.52% | 54,707 | - |
| 577 | GLMD | Galmed Pharmaceuticals Ltd. | 5.16M | -13.56% | 1,287,064 | - |
| 578 | REVB | Revelation Biosciences, Inc. | 5.06M | -0.72% | 120,013 | - |
| 579 | JAGX | Jaguar Health, Inc. | 5.01M | -19.28% | 204,562 | 11.79M |
| 580 | ASBP | Aspire Biopharma Holdings, Inc. | 4.91M | -6.15% | 27,446,095 | 1.94K |
| 581 | ENTO | Entero Therapeutics, Inc. | 4.89M | -19.88% | 460,139 | - |
| 582 | PMCB | PharmaCyte Biotech, Inc. | 4.85M | -5.18% | 15,260 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.75M | -4.76% | 76,439 | 15.78K |
| 584 | KALA | KALA BIO, Inc. | 4.44M | -8.10% | 165,375 | - |
| 585 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.31M | 1.94% | 40,516 | 1.36M |
| 586 | HCWB | HCW Biologics Inc. | 4.26M | -17.80% | 120,555 | 422.03K |
| 587 | GRI | GRI Bio, Inc. | 4.25M | -5.59% | 205,558 | - |
| 588 | GNPX | Genprex, Inc. | 4.17M | -9.49% | 286,090 | - |
| 589 | OGEN | Oragenics, Inc. | 4.00M | -11.44% | 160,303 | - |
| 590 | SPRC | SciSparc Ltd. | 3.99M | 1.65% | 14,400 | 927.00K |
| 591 | PTIX | Protagenic Therapeutics, Inc. | 3.87M | -8.18% | 67,216 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 3.87M | 0.07% | 3,103 | - |
| 593 | BGMS | Bio Green Med Solution, Inc. | 3.79M | -3.73% | 29,780 | 81.00K |
| 594 | ARTL | Artelo Biosciences, Inc. | 3.73M | -2.12% | 50,292 | - |
| 595 | ELAB | PMGC Holdings Inc. | 3.65M | 0.41% | 64,542 | -241.53K |
| 596 | ONCO | Onconetix, Inc. | 3.64M | -7.51% | 14,551 | 1.22M |
| 597 | KTTA | Pasithea Therapeutics Corp. | 3.54M | -27.89% | 1,015,723 | - |
| 598 | AZTR | Azitra, Inc. | 3.36M | -3.91% | 214,509 | 7.50K |
| 599 | SLRX | Salarius Pharmaceuticals, Inc. | 3.31M | -8.82% | 1,468,826 | - |
| 600 | XRTX | XORTX Therapeutics Inc. | 3.22M | -1.02% | 42,018 | - |
| 601 | SCNI | Scinai Immunotherapeutics Ltd. | 3.12M | 0.65% | 15,696 | 1.15M |
| 602 | ENVB | Enveric Biosciences, Inc. | 3.03M | 3.00% | 53,800 | - |
| 603 | GTBP | GT Biopharma, Inc. | 2.42M | 3.74% | 788,841 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 2.39M | -16.09% | 89,497 | 104.90K |
| 605 | INDP | Indaptus Therapeutics, Inc. | 2.29M | -10.39% | 67,319 | - |
| 606 | MLEC | Moolec Science SA | 2.26M | 1.02% | 58,689 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 1.91M | -2.33% | 27,262 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.66M | -8.61% | 121,745 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.39M | -3.89% | 41,214 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.11M | -6.42% | 11,181,454 | - |
| 611 | CDT | CDT Equity Inc. | 665.99K | -16.75% | 112,189 | - |
| 612 | ADTX | Aditxt, Inc. | 153.26K | -14.71% | 166,129 | 5.95K |